education
Download App
Indonesia
search
Masuk
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Country
Hong Kong
India
Indonesia
Malaysia
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
search
UserName
Profession
Email
Account
Manage Account
Change Password
Sign Out
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Other Services
Education
Download App
Country
Indonesia
Hong Kong
India
Indonesia
Malaysia
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
Account
Masuk
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Iklan
Iklan
MIMS home
Drugs
Info
Simduva
Simduva
isoxsuprine
Manufacturer:
Simex
SELECT
Concise Prescribing Info
Bahasa Concise Prescribing Info
Concise Prescribing Info
Bahasa Concise Prescribing Info
Concise Prescribing Info
Contents
Isoxsuprine
Indications/Uses
Peripheral vascular disorders eg, arteriosclerosis obliterans, thromboangiitis obliterans (Buerger’s disease).
Dosage/Direction for Use
1 tab 3-4 times daily.
Administration
Should be taken with food: Take immediately after meals.
Contraindications
Hypersensitivity. Arterial haemorrhage, ischemic heart disease, severe anemia, premature placental abruption, postpartum. Neonates & childn.
Special Precautions
Monitor BP & heart rate especially in elderly. Lactation.
Adverse Reactions
Skin rash, nausea, vomiting, hypotension, palpitation, increased free fatty acid blood conc.
View
ADR Reporting Link
MIMS Class
Peripheral Vasodilators & Cerebral Activators
/
Drugs Acting on the Uterus
ATC Classification
C04AA01 - isoxsuprine ; Belongs to the class of 2-amino-1-phenylethanol derivative agents. Used as peripheral vasodilators.
Regulatory Classification
K
Presentation/Packing
Form
Simduva tab 20 mg
Packing/Price
3 × 10's (Rp120,000/boks)
Iklan
Iklan
Iklan
Iklan
Iklan
Iklan
Iklan
Daftar Gratis untuk melanjutkan membaca
Lanjutkan dengan Google
Daftar dengan email
Sudah punya akun?
Masuk
Daftar Gratis untuk melanjutkan membaca
Lanjutkan dengan Google
Daftar dengan email
Sudah punya akun?
Masuk